A Window of Opportunity Study of KTN3379 in Surgically Resectable Head and Neck Cancer Patients

Clinical trial NCT02473731 · COMPLETED

Trial details

NCT number: NCT02473731
Sponsor: Celldex Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Head and Neck

Start date: 2015-10-01
Primary completion: 2016-09-22
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.